This move is archived. Current quotes and coverage live on the stock page.
Get GENX alerts:
GenixPharmaceuticals Corporation's stock has taken a significant hit, dropping 25% in just one day.
In the latest trading session, GenixPharmaceuticals Corporation (GENX.V) saw its stock price plummet by 25%, closing at just CA$0.01. This sharp decline raises concerns among investors about the company's financial health and future prospects.
Investor takeaway: With no recent positive news to boost investor confidence, the dramatic drop in Genix's stock price highlights the volatility and risks of investing in small-cap pharmaceutical companies.
Advertisement
GenixPharmaceucticals Corporation
GENX.V
GENX.V
GenixPharmaceucticals Corporation
WealthAwesomeMarket cap
$1.22M
52W high
$0.04
52W low
$0.02
1W change
+0.00%
Beta
0.40
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GENX's historical volatility
30-Day Vol
214.0%
Annualized
90-Day Vol
276.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.02
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.02 | C$0.01 – C$0.04 |
| 60 trading days | C$0.02 | C$0.01 – C$0.05 |
| 90 trading days | C$0.02 | C$0.00 – C$0.06 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Bull case
If Genix can stabilize its operations and show a clear path to profitability, there may be potential for recovery in the long term.
Bear case
Continued losses and a lack of investor interest could lead to further declines, especially given the company's low market cap of CA$918,361.
Understanding the Decline
Advertisement
The 25% drop in Genix's stock price can be attributed to a lack of recent positive news or developments that could reassure investors. The company's market cap remains low, which often leads to increased volatility in stock prices.
What Lies Ahead for Investors?
Investors should closely monitor GenixPharmaceuticals Corporation's financial health and any future announcements. The recent private placement and changes in leadership could be pivotal in determining the company's next steps. For more details on their financials, check out our analysis on GENX.V.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
